View in EDS HTML Full Text PDF Full Text

Gentiopicrin-Loaded Chitosan Nanoparticles as a Topical Agent for the Treatment of Psoriasis.

Saved in:
Bibliographic Details
Title: Gentiopicrin-Loaded Chitosan Nanoparticles as a Topical Agent for the Treatment of Psoriasis.
Authors: Cheng, Guohua1 (AUTHOR) chengguohua@stu.scu.edu.cn, Zhang, Xiaojie2 (AUTHOR) zhangxiaojie@iccas.ac.cn, Zhang, Huiling3,4 (AUTHOR) zhanghl945@hotmail.com, Feng, Zhixuan3,4 (AUTHOR) fengzx010116@hotmail.com, Cai, Jiaxiu1 (AUTHOR) 2021222040091@stu.scu.edu.cn, Li, Jingjing1 (AUTHOR) li_jingjing@stu.scu.edu.cn, Du, Libo2,4 (AUTHOR) dulibo@iccas.ac.cn, Liu, Ke1 (AUTHOR) dulibo@iccas.ac.cn
Source: Nanomaterials (2079-4991). Apr2024, Vol. 14 Issue 7, p610. 18p.
Subjects: Keratinocyte differentiation, Oncostatin M, Psoriasis, Cell migration, Chitosan, Liposomes, Drug delivery systems, Inhibition of cellular proliferation
Abstract: Psoriasis, a chronic inflammatory skin disease induced by various factors, including genetic factors, immune factors, environmental factors, and psychological factors, is characterized by thickening of the epidermis, excessive proliferation of keratinocytes, abnormal differentiation, and an excessive inflammatory response. Traditional treatments for psoriasis still face challenges because of limited curative effects, notable side effects, and a tendency for recurrence. In contrast, topical therapy provides a favorable option for psoriasis treatment because of its noninvasive and self-administered method. In this study, gentiopicrin (Gen) is encapsulated in the liposomes to form a nanodrug, and then chitosan is covered on the nanodrug to assemble the nanodrug delivery system (CS@Gen), which is used as a topical agent for treating psoriasis. Then M5 (a mixture of five pro-inflammatory cytokines, i.e., IL-17A, IL-22, IL-1α, oncostatin M, and TNF-α)-induced HacaT cells and imiquimod-induced psoriasis mouse models are established, whose results show that CS@Gen induces apoptosis and inhibits the proliferation and cell migration of psoriasis keratinocytes. Additionally, the application of CS@Gen cream can significantly reduce epidermal thickness, diminish skin scaling, and improve other related mechanisms in mice affected by psoriasis. Meanwhile, the prepared CS@Gen can significantly reduce the expression levels of IL-17a, Cxcl2, S100a, Mki67, and other related inflammatory factors, resulting in indirectly inhibiting the inflammation of keratinocytes. In summary, the present study provides an ideal loading for an anti-inflammatory and immunomodulatory drug delivery system for the treatment of psoriasis. [ABSTRACT FROM AUTHOR]
Copyright of Nanomaterials (2079-4991) is the property of MDPI and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Engineering Source
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: egs
DbLabel: Engineering Source
An: 176596846
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Gentiopicrin-Loaded Chitosan Nanoparticles as a Topical Agent for the Treatment of Psoriasis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Cheng%2C+Guohua%22">Cheng, Guohua</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> chengguohua@stu.scu.edu.cn</i><br /><searchLink fieldCode="AR" term="%22Zhang%2C+Xiaojie%22">Zhang, Xiaojie</searchLink><relatesTo>2</relatesTo> (AUTHOR)<i> zhangxiaojie@iccas.ac.cn</i><br /><searchLink fieldCode="AR" term="%22Zhang%2C+Huiling%22">Zhang, Huiling</searchLink><relatesTo>3,4</relatesTo> (AUTHOR)<i> zhanghl945@hotmail.com</i><br /><searchLink fieldCode="AR" term="%22Feng%2C+Zhixuan%22">Feng, Zhixuan</searchLink><relatesTo>3,4</relatesTo> (AUTHOR)<i> fengzx010116@hotmail.com</i><br /><searchLink fieldCode="AR" term="%22Cai%2C+Jiaxiu%22">Cai, Jiaxiu</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> 2021222040091@stu.scu.edu.cn</i><br /><searchLink fieldCode="AR" term="%22Li%2C+Jingjing%22">Li, Jingjing</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> li_jingjing@stu.scu.edu.cn</i><br /><searchLink fieldCode="AR" term="%22Du%2C+Libo%22">Du, Libo</searchLink><relatesTo>2,4</relatesTo> (AUTHOR)<i> dulibo@iccas.ac.cn</i><br /><searchLink fieldCode="AR" term="%22Liu%2C+Ke%22">Liu, Ke</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> dulibo@iccas.ac.cn</i>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Nanomaterials+%282079-4991%29%22">Nanomaterials (2079-4991)</searchLink>. Apr2024, Vol. 14 Issue 7, p610. 18p.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Keratinocyte+differentiation%22">Keratinocyte differentiation</searchLink><br /><searchLink fieldCode="DE" term="%22Oncostatin+M%22">Oncostatin M</searchLink><br /><searchLink fieldCode="DE" term="%22Psoriasis%22">Psoriasis</searchLink><br /><searchLink fieldCode="DE" term="%22Cell+migration%22">Cell migration</searchLink><br /><searchLink fieldCode="DE" term="%22Chitosan%22">Chitosan</searchLink><br /><searchLink fieldCode="DE" term="%22Liposomes%22">Liposomes</searchLink><br /><searchLink fieldCode="DE" term="%22Drug+delivery+systems%22">Drug delivery systems</searchLink><br /><searchLink fieldCode="DE" term="%22Inhibition+of+cellular+proliferation%22">Inhibition of cellular proliferation</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: Psoriasis, a chronic inflammatory skin disease induced by various factors, including genetic factors, immune factors, environmental factors, and psychological factors, is characterized by thickening of the epidermis, excessive proliferation of keratinocytes, abnormal differentiation, and an excessive inflammatory response. Traditional treatments for psoriasis still face challenges because of limited curative effects, notable side effects, and a tendency for recurrence. In contrast, topical therapy provides a favorable option for psoriasis treatment because of its noninvasive and self-administered method. In this study, gentiopicrin (Gen) is encapsulated in the liposomes to form a nanodrug, and then chitosan is covered on the nanodrug to assemble the nanodrug delivery system (CS@Gen), which is used as a topical agent for treating psoriasis. Then M5 (a mixture of five pro-inflammatory cytokines, i.e., IL-17A, IL-22, IL-1α, oncostatin M, and TNF-α)-induced HacaT cells and imiquimod-induced psoriasis mouse models are established, whose results show that CS@Gen induces apoptosis and inhibits the proliferation and cell migration of psoriasis keratinocytes. Additionally, the application of CS@Gen cream can significantly reduce epidermal thickness, diminish skin scaling, and improve other related mechanisms in mice affected by psoriasis. Meanwhile, the prepared CS@Gen can significantly reduce the expression levels of IL-17a, Cxcl2, S100a, Mki67, and other related inflammatory factors, resulting in indirectly inhibiting the inflammation of keratinocytes. In summary, the present study provides an ideal loading for an anti-inflammatory and immunomodulatory drug delivery system for the treatment of psoriasis. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of Nanomaterials (2079-4991) is the property of MDPI and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=egs&AN=176596846
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3390/nano14070610
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 18
        StartPage: 610
    Subjects:
      – SubjectFull: Keratinocyte differentiation
        Type: general
      – SubjectFull: Oncostatin M
        Type: general
      – SubjectFull: Psoriasis
        Type: general
      – SubjectFull: Cell migration
        Type: general
      – SubjectFull: Chitosan
        Type: general
      – SubjectFull: Liposomes
        Type: general
      – SubjectFull: Drug delivery systems
        Type: general
      – SubjectFull: Inhibition of cellular proliferation
        Type: general
    Titles:
      – TitleFull: Gentiopicrin-Loaded Chitosan Nanoparticles as a Topical Agent for the Treatment of Psoriasis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Cheng, Guohua
      – PersonEntity:
          Name:
            NameFull: Zhang, Xiaojie
      – PersonEntity:
          Name:
            NameFull: Zhang, Huiling
      – PersonEntity:
          Name:
            NameFull: Feng, Zhixuan
      – PersonEntity:
          Name:
            NameFull: Cai, Jiaxiu
      – PersonEntity:
          Name:
            NameFull: Li, Jingjing
      – PersonEntity:
          Name:
            NameFull: Du, Libo
      – PersonEntity:
          Name:
            NameFull: Liu, Ke
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: Apr2024
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 20794991
          Numbering:
            – Type: volume
              Value: 14
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: Nanomaterials (2079-4991)
              Type: main
ResultId 1